Site Search
Results
-
TR-439: Methylphenidate Hydrochloride (CASRN 298-59-9) in F344...
... Cancer Res. 45, 3415-3443. Whalen, C.K., and Henker, B. (1991). Therapies for hyperactive children: Comparisons, combinations, and compromises. J. Consult. Clin. Psychol. 59, ...
Size: 15.1MB https://ntp.niehs.nih.gov/go/tr439 -
TR-457: Salicylazosulfapyridine (CASRN 599-79-1) in F344 Rats...
... Scand. J. Gastroenterol. 25 (Suppl. 172), 66-68. Bruckstein, A.H. (1990). New salicylate therapies for ulcerative colitis. Postgrad. Med. J. 88, 79-82, 84, 89. Capell, H.A., ...
Size: 18.7MB https://ntp.niehs.nih.gov/go/tr457 -
TR-469: AZT (CASRN 30516-87-1) and AZT/a-Interferon A/D B6C3F1Mice...
... Therefore, a number of combination therapies involving AZT and other drugs have been ... Hematologic effects of AIDS therapies. Hematol. Oncol. Clin. North Am. 5, 229-248. Poli, ...
Size: 15.9MB https://ntp.niehs.nih.gov/go/tr469 -
TR-569: Mixtures of 3'-Azido-3'-Deoxythymidine (AZT), Lamivudine...
... Mutational analysis of the mito- chondrial tRNA genes and flanking regions in umbilical cord tissue from uninfected infants receiving AZT- based therapies for prophylaxis of HIV-1. ...
Size: 3.6MB https://ntp.niehs.nih.gov/go/tr569 -
TR-587: Tetrabromobisphenol A (CASRN 79-94-7) in F344/NTac Rats...
... producing tumors (e.g., granulosa cell tumor), and some estrogen replacement therapies. ... exogenous estrogen therapies, nulliparity, tamoxifen therapy, and pelvic irradiation. ...
Size: 3.7MB https://ntp.niehs.nih.gov/go/tr587 -
RoC Background Document for Hepatitis B Virus; June 11, 2003
... infection; it is one of three licensed therapies for chronic hepatitis and is sometimes ... Lamivudine and adefovir dipivoxil are the other approved therapies for chronic hepatitis. ...
Size: 2.8MB https://ntp.niehs.nih.gov/sites/default/files/ntp/newhomeroc/roc11/hbv_rg2public_508.pdf -
ICCVAM Biennial Progress Report 2006-2007
... McFarland RD. 2007. 3Rs in gene therapies and cellular therapies in USA. Abstract. Sixth World Congress on Alternatives and Animal Use in the Life Sciences, Tokyo, Japan, August ...
Size: 10.1MB https://ntp.niehs.nih.gov/iccvam/docs/annrpt/biennialrpt2007-508.pdf -
ICCVAM Biennial Progress Report 2018-2019 (text version)
... The goal of these models is to advance therapies for degenerative retinal diseases such as age-related macular degeneration, glaucoma, and diabetic retinopathy. In this phase of ...
Size: 1.0MB https://ntp.niehs.nih.gov/iccvam/docs/annrpt/iccvam-rpt-2018-2019.pdf -
ICCVAM Background Review Document: Validation Status of Five...
... such as cellular therapies, medical devices and pollution control in the work place. ... 50 years, it fails for important new therapies such as cellular products or ...
Size: 10.6MB https://ntp.niehs.nih.gov/iccvam/docs/pyrogen/brd/pyrobrd2008.pdf -
ICCVAM Test Method Evaluation Report: Five In Vitro Pyrogenicity...
... More work will have to be carried out to understand the types of materials that could be tested in these assays and how they would be handled (e.g., cell therapies and implants). ...
Size: 7.4MB https://ntp.niehs.nih.gov/iccvam/docs/pyrogen/tmer/pyrotmer2008.pdf
to Top